Three Orphans One Should Know: Red Scalp, Red Ear, and Red Scrotum Syndrome

    Uwe Wollina
    Image of study
    TLDR The document concludes that early recognition and appropriate treatment of red scalp, red ear, and red scrotum syndromes can lead to remission.
    The document discusses three lesser-known dermatological conditions: red scalp syndrome, red ear syndrome, and red scrotum syndrome, which are considered orphan diseases due to their low prevalence. Red scalp syndrome is characterized by an erythematous scalp with symptoms such as itching, stinging, or burning sensations, and is resistant to potent topical steroids or anti-seborrheic therapy. It may be related to rosacea and can be treated with oral tetracycline and UV light protection, or isotretinoin if the former is ineffective. Red ear syndrome presents as a paroxysmal condition with tenderness and warmth of the external ear, potentially triggered by stress or temperature changes, and can be treated with gabapentin, amitriptyline, or NSAIDs, along with cooling. Red scrotum syndrome features persistent erythema and burning sensations, primarily affecting older males, and may result from topical corticosteroid misuse. It can be treated with topical calcineurin inhibitors, gabapentin, or doxycycline. Early recognition of these conditions can lead to complete remission, but long-standing cases are more resistant to treatment. Dermatologists should be aware of these conditions to prevent delayed diagnosis and inappropriate treatment.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 644 results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community 2.5 years Minoxidil and HRT, CPA->Lupron +Minox 5%

      in Transgender  611 upvotes 1 week ago
      The user experienced significant hair regrowth after 2.5 years of using Minoxidil 5% and hormone replacement therapy (HRT) with Lupron, despite initial scalp irritation. Finasteride was ineffective for them.

      community 14-month update - dut, min, niz, 1.5mm roller.

      in Progress Pictures  443 upvotes 10 months ago
      A user shared a 14-month hair loss treatment update using dutasteride, minoxidil foam, a 1.5mm derma roller, and Nizoral, with noticeable hair regrowth and no side effects. The discussion highlights the effectiveness of microneedling in combination with topical treatments, with many users agreeing it significantly enhances results.

    Similar Research

    5 / 1000+ results
      Atlas of Geriatric Dermatology

      research Atlas of Geriatric Dermatology

      2 citations, January 2014 in “Springer eBooks”
      The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.
      Autoimmune Disease and Hair Loss

      research Autoimmune Disease and Hair Loss

      35 citations, October 2012 in “Dermatologic Clinics”
      Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.
      What's New in Cicatricial Alopecia?

      research What's New in Cicatricial Alopecia?

      16 citations, January 2013 in “Indian Journal of Dermatology, Venereology and Leprology”
      New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.
      Alopecia as a Systemic Disease

      research Alopecia as a Systemic Disease

      7 citations, July 2019 in “Clinics in Dermatology”
      Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.